GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.
